Skip to main content

Animations

MJFF Publications

2561 - 2570 of 6420 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • 2023
  • 2023
  • 2024
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Three-step docking by WIPI2, ATG16L1, and ATG3 delivers LC3 to the phagophore
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adj8027
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Improving Dysarthric Speech Segmentation With Emulated and Synthetic Augmentation
    Journal Name: IEEE Journal of Translational Engineering in Health and Medicine
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1109/jtehm.2024.3375323
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology
    Journal Name: Clinical Chemistry
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/clinchem/hvad139
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100712
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/trc2.12461
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Why Therapeutic Trials Fail in Primary Tauopathies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29322
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29358
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13729
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Abnormal dynamic functional connectivity changes correlated with non-motor symptoms of Parkinson’s disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2023.1116111
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-32480-0
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.